Evidence map›Paper›PMID 31024701›Full record

ArticleFood science & nutrition2019

Vitamin A deficiency execrates Lewis lung carcinoma via induction of type 2 innate lymphoid cells and alternatively activates macrophages.

Weiwei Cui, Wenxin Zhang, Xiaofeng Yuan, Shanshan Liu, Meng Li, Junqi Niu, Peng Zhang, Dong Li

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Review
  5. Review
  6. The Role of Innate Lymphoid Cells in Cancer Development and Immunotherapy.Frontiers in cell and developmental biology · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Weiwei CuiDepartment of Nutrition and Food Hygiene, School of Public Health Jilin University Changchun China.
Wenxin ZhangDepartment of Pathology The First Hospital of Jilin University Changchun China.
Xiaofeng YuanDepartment of Pediatrics Affiliated Hospital of Changchun University of Chinese Medicine Changchun China.
Shanshan LiuDepartment of Immunology, College of Basic Medical Sciences Jilin University Changchun China.
Meng LiDepartment of Epidemiology and Biostatistics, School of Public Health Jilin University Changchun China.
Junqi NiuDepartment of Hepatology The First Hospital of Jilin University Changchun China.
Peng ZhangDepartment of Thoracic Surgery The First Hospital of Jilin University Changchun China.
Dong LiDepartment of Immunology, College of Basic Medical Sciences Jilin University Changchun China.ORCID https://orcid.org/0000-0002-2508-3282
Jilin University · CNChangchun University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung carcinoma is still associated with high rates of morbidity and mortality despite the advances in cancer therapy achieved in last decades. Recent studies showed that immune responses played a crucial role in the developments of cancers including lung cancer. Type 1 immune response could promote classical activated macrophages (CAMs) with antitumor properties. On the contrast, type 2 immune response could lead to the polarization of alternatively activated macrophages (AAMs) which could promote the growth and metastasis of tumor. Our previous research showed that vitamin A deficiency could promote the type 2 immune response but not the type 1 immune response. Whether vitamin A deficiency has detrimental effect for lung carcinoma need further investigate.

aimTo investigate the effect of vitamin A deficiency in lung cancer and the potential mechanisms.

methodsMice were fed with normal diet or vitamin A deficiency diet for 2 weeks, and then, Lewis lung cancer (LLC) cells dissolved in Matrigel Matrix were planted on the left lower lope of lungs. Mice were sacrificed 28 days after the plantation of tumor cells, the tumor size, cytokine profile in bronchoalveolar lavage fluid (BALF), numbers of type 2 innate lymphoid cells (ILC2s), and macrophage phenotypes in the lung were measured. The overall survival rate was also monitored throughout the experiments.

resultsVitamin A deficiency diet fed tumor-bearing mice have lower survival rate (

conclusionVitamin A deficiency could promote the pathogeneses of lung carcinoma via induction of ILC2s and polarizing AAMs.

Indexed as

alternatively activated macrophagescytokineILC2lung carcinomavitamin A

Identifiers

PMID31024701
PMCPMC6475724
OpenAlexW2912435150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.